KalVista Pharmaceuticals, Inc. - KALV

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$1.495B

QoQ value delta ($000)

+$411.9M (+38.02%)

Implied price effect (QoQ)

+23.78%

Total shares

74,795,802

QoQ shares delta

+7,720,569 (+11.51%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 185 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Venrock Adviser, LLC	130,331	6,474,485	4.86%
Frazier Life Sciences Management, L.P.	99,867	4,961,108	2.57%
SUVRETTA CAPITAL MANAGEMENT, LLC	95,994	4,768,712	2.45%
TANG CAPITAL MANAGEMENT LLC	92,065	4,573,530	4.68%
BlackRock, Inc.	76,411	3,795,897	0.0%
SILVERARC CAPITAL MANAGEMENT, LLC	57,902	2,876,407	5.91%
Capital World Investors	56,536	2,808,583	0.01%
Caption Management, LLC	48,915	2,430,000	0.29%
Point72 Asset Management, L.P.	43,016	2,136,940	0.06%
VANGUARD GROUP INC	40,520	2,509,020	0.0%
STATE STREET CORP	39,371	1,955,844	0.0%
MILLENNIUM MANAGEMENT LLC	38,491	1,912,146	0.02%
Vestal Point Capital, LP	37,240	1,850,000	1.04%
Parkman Healthcare Partners LLC	36,948	1,835,506	3.81%
VANGUARD CAPITAL MANAGEMENT LLC	36,847	1,830,467	0.0%
Kynam Capital Management, LP	36,655	1,820,954	2.26%
Woodline Partners LP	30,394	1,509,920	0.11%
Octagon Capital Advisors LP	29,188	1,450,000	3.23%
Squadron Capital Management LLC	26,171	1,300,100	9.59%
EMERALD ADVISERS, LLC	25,444	1,264,023	0.81%
ARMISTICE CAPITAL, LLC	24,880	1,236,000	0.44%
Elmind Capital, LP	20,558	1,021,300	5.84%
GEODE CAPITAL MANAGEMENT, LLC	20,059	996,235	0.0%
Spruce Street Capital LP	18,070	897,681	4.34%
Freestone Grove Partners LP	17,772	882,906	0.13%